COLORECTAL CANCER

Effect of folate supplementation on mucosal cell proliferation in high risk patients for colon cancer

K Khosraviani¹, H P Weir¹, P Hamilton², J Moorehead³, K Williamson²

¹ Department of Surgery, Queen's University of Belfast, UK
² Department of Pathology, Cancer Research Centre, Queen's University of Belfast, UK
³ Gastrointestinal Surgical Department, Ulster Hospital Dundonald, UK

Correspondence to:
Correspondence to:
Mr K Khosraviani, Department of Surgery, Institute of Clinical Science, Royal Victoria Hospital, Grosvenor Road, Belfast BT12 6BJ, UK

Aims: Intracellular folate deficiency has been implicated in colonic carcinogenesis in epidemiological studies and animal and human cancer models. Our aim was to determine the effect of folate supplementation on patients with recurrent adenomatous polyps using rectal mucosal cell proliferation as a biomarker.

Patients and methods: Eleven patients with recurrent adenomatous polyps of the colon were randomised into a treatment group (n=6) receiving a dietary supplement of 2 mg folic acid per day for three months and a control group (n=5) receiving a placebo. Rectal biopsies where taken at 10 cm from the anal verge prior to supplementation and repeated at four, 12, and 18 weeks from the start of the supplementation. Each biopsy was immediately incubated in culture medium enriched with bromodeoxyuridine (BrdU). The S phase cells which incorporated BrdU into their DNA were identified following immunohistochemical staining. Twenty five orientated crypts were identified for each time point and the number and position of BrdU positive and BrdU negative cells were counted. BrdU labelling indices (LIs) were calculated for the entire crypt and for each of five equal compartments running consequently from the base to the luminal surface.

Results: The LI of the treatment group (9.1 (6.7, 12.3)) and the control group (9.3 (7.8, 10.3)) were comparable at the start. Over the duration of the supplementation period, LI in the control group did not alter significantly (9.3 (7.8, 10.3) v 9.6 (8.9, 10.4)). However, LI of the folate treated group was lowered after 12 weeks of supplementation (9.1 (6.7, 12.3) v 7.4 (5.3, 9.6)). Analysis of the LI for compartments within the crypt showed that the most significant drop in number of proliferating cells was in the upper most regions of the crypt.

Conclusion: These data indicate that (a) folate supplementation decreases colonic mucosal cell proliferation in a high risk group for colon cancer and (b) the most significant reduction takes place at the luminal aspect of the crypt.

Keywords: adenomatous polyps; chemoprevention; folate; mucosal cell proliferation

Abbreviations: BrdU, bromodeoxyuridine; LI, labelling index; CRC, colorectal cancer; PBS, phosphate buffered saline

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Luebeck, E. G., Moolgavkar, S. H., Liu, A. Y., Boynton, A., Ulrich, C. M. (2008). Does Folic Acid Supplementation Prevent or Promote Colorectal Cancer? Results from Model-Based Predictions. Cancer Epidemiol. Biomarkers Prev. 17: 1360-1367 [Abstract] [Full Text]  
• Powers, H. J., Hill, M. H., Welfare, M., Spiers, A., Bal, W., Russell, J., Duckworth, Y., Gibney, E., Williams, E. A., Mathers, J. C. (2007). Responses of Biomarkers of Folate and Riboflavin Status to Folate and Riboflavin Supplementation in Healthy and Colorectal Polyp Patients (The FAB2 Study). Cancer Epidemiol. Biomarkers Prev. 16: 2128-2135 [Abstract] [Full Text]  
• van den Donk, M., Pellis, L., Crott, J. W., van Engeland, M., Friederich, P., Nagengast, F. M., van Bergeijk, J. D., de Boer, S. Y., Mason, J. B., Kok, F. J., Keijer, J., Kampman, E. (2007). Folic Acid and Vitamin B-12 Supplementation Does Not Favorably Influence Uracil Incorporation and Promoter Methylation in Rectal Mucosa DNA of Subjects with Previous Colorectal Adenomas. J. Nutr. 137: 2114-2120 [Abstract] [Full Text]  
• Rafter, J., Bennett, M., Caderni, G., Clune, Y., Hughes, R., Karlsson, P. C, Klinder, A., O'Riordan, M., O'Sullivan, G. C, Pool-Zobel, B., Rechkemmer, G., Roller, M., Rowland, I., Salvadori, M., Thijs, H., Van Loo, J., Watzl, B., Collins, J. K (2007). Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am. J. Clin. Nutr. 85: 488-496 [Abstract] [Full Text]  
• Wasson, G. R., McGlynn, A. P., McNulty, H., O'Reilly, S. L., McKelvey-Martin, V. J., McKerr, G., Strain, J. J., Scott, J., Downes, C. S. (2006). Global DNA and p53 Region-Specific Hypomethylation in Human Colonic Cells Is Induced by Folate Depletion and Reversed by Folate Supplementation. J. Nutr. 136: 2748-2753 [Abstract] [Full Text]  
• Van Guelpen, B, Hultdin, J, Johansson, I, Hallmans, G, Stenling, R, Riboli, E, Winkvist, A, Palmqvist, R (2006). Low folate levels may protect against colorectal cancer. Gut 55: 1461-1466 [Abstract] [Full Text]  
• Ma, D. W.L., Finnell, R. H., Davidson, L. A., Callaway, E. S., Spiegelstein, O., Piedrahita, J. A., Salbaum, J. M., Kappen, C., Weeks, B. R., James, J., Bozinov, D., Lupton, J. R., Chapkin, R. S. (2005). Folate Transport Gene Inactivation in Mice Increases Sensitivity to Colon Carcinogenesis. Cancer Res. 65: 887-897 [Abstract] [Full Text]  
• Bashir, O., FitzGerald, A.J., Goodlad, R.A. (2004). Both suboptimal and elevated vitamin intake increase intestinal neoplasia and alter crypt fission in the ApcMin/+ mouse. Carcinogenesis 25: 1507-1515 [Abstract] [Full Text]  
• Kim, Y.-I. (2004). Folate and DNA Methylation: A Mechanistic Link between Folate Deficiency and Colorectal Cancer?. Cancer Epidemiol. Biomarkers Prev. 13: 511-519 [Abstract] [Full Text]  
• Kim, Y.-I. (2003). Role of Folate in Colon Cancer Development and Progression. J. Nutr. 133: 3731S-3739 [Abstract] [Full Text]  
• Little, J., Sharp, L., Duthie, S., Narayanan, S. (2003). Colon Cancer and Genetic Variation in Folate Metabolism: The Clinical Bottom Line. J. Nutr. 133: 3758S-3766 [Abstract] [Full Text]  
• Bailey, L. B., Rampersaud, G. C., Kauwell, G. P. A. (2003). Folic Acid Supplements and Fortification Affect the Risk for Neural Tube Defects, Vascular Disease and Cancer: Evolving Science,. J. Nutr. 133: 1961S-1968 [Abstract] [Full Text]